相关实验视频
Updated: Jul 5, 2025

Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
从COVID-19中康复后与慢性咳的发展相关的相关因素
Yoshihiro Kanemitsu1, Kensuke Fukumitsu1, Akio Niimi2
1Department of Respiratory Medicine, Allergy, and Clinical Immunology, Nagoya City University of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan; Aichi Hospital, 18-1 Kuriyado, Kakemachi, Okazaki, Aichi, Japan.
COVID-19 后的慢性咳与胃肠道问题和之前的咳史有关. 这些因素显著预测咳的流行程度和严重程度,影响日常生活质量.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 胃肠病学 胃肠病学
背景情况:
- 咳是COVID-19后的一个常见症状.
- 在COVID-19感染后影响慢性咳的因素尚未得到充分了解.
- 这项研究调查了COVID-19恢复后持续咳的预测因素.
研究的目的:
- 在COVID-19后患者中确定与慢性咳相关的因素.
- 评估咳对COVID-19后生活质量 (QoL) 的影响.
- 探索咳,胃肠道症状和喉感觉之间的关系.
主要方法:
- 在康复158天后,对170名COVID-19幸存者进行了一项调查.
- 使用问卷和医疗记录评估咳的流行程度,严重程度,咳特异性 QoL,反流和喉感觉.
- 多变量回归分析确定了咳相关结果的预测因素.
主要成果:
- 咳影响了24%的参与者,并且经常与胃肠道症状有关.
- 预先存在的慢性咳,胃肠道症状和唾液是COVID-19后咳的重要预测因素.
- 咳特异性QOL与反流和喉感觉相关,但不是急性阶段的QOL.
结论:
- 后COVID-19咳对日常生活产生负面影响.
- 胃肠道症状可能在COVID-19后咳的发展中发挥关键作用.
- 针对胃肠道症状可能对管理COVID-19后持续咳至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumonia II: Pathophysiology

